| mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |